Skip to main content
HCPCS Level II/M-Codes/M1232

M1232 HCPCS Level II Code: Patient receives hcv antibody test with reactive result

M1232 is the authoritative medical code for Patient receives hcv antibody test with reactive result. This classification is used in medical billing and clinical recording to specify the clinical criteria for patient receives hcv antibody test with reactive result (HCPCS Level II M1232), ensuring healthcare documentation aligns with current federal coding standards.

Billing Status: Processed within HCPCS Level II standards. CMS regulatory guidelines apply.

Medicare Coverage & Payment

  • Medicare coverage: Carrier judgment (CMS coverage code C)
  • Payment category: Service not separately priced (pricing indicator 00)
  • BETOS: Z2
  • Effective: January 1, 2024

Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.

Official Registry Overview & Definition

Patient receives hcv antibody test with reactive result is a HCPCS Level II code (M1232) for a Medicare-covered supply, service, or procedure. Short description: Pt hcv tst reactive result.

Nearest Codes in This Family

Official HCPCS Level II classifications closest to M1232 in its code family, with their registry titles.

  • M1227 — Evidence-based therapy was prescribed
  • M1228 — Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, has hcv treatment initiated within 3 months of the reactive hcv antibody test
  • M1229 — Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, is referred within 1 month of the reactive hcv antibody test to a clinician who treats hcv infection
  • M1230 — Patient has a reactive hcv antibody test and does not have a follow up hcv viral test, or patient has a reactive hcv antibody test and has a follow up hcv viral test that detects hcv viremia and is not referred to a clinician who treats hcv infection within 1 month and does not have hcv treatment initiated within 3 months of the reactive hcv antibody test, reason not given
  • M1231 — Patient receives hcv antibody test with nonreactive result
  • M1233 — Patient does not receive hcv antibody test or patient does receive hcv antibody test but results not documented, reason not given
  • M1234 — Patient has a reactive hcv antibody test, and has a follow up hcv viral test that does not detect hcv viremia
  • M1235 — Documentation or patient report of hcv antibody test or hcv rna test which occurred prior to the performance period
  • M1236 — Baseline mrs > 2
  • M1237 — Patient reason for not screening for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety (e.g., patient declined or other patient reasons)